Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) CEO Helen Torley sold 10,000 shares of the stock in a transaction on Tuesday, August 29th. The shares were sold at an average price of $42.40, for a total value of $424,000.00. Following the completion of the transaction, the chief executive officer now owns 623,666 shares of […] The post Halozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Sells $424,000.00 in Stock first appeared on Daily Political .
https://www.dailypolitical.com/2023/09/03/halozyme-therapeutics-inc-nasdaqhalo-ceo-sells-424000-00-in-stock.html#dailypolitical
Du måste logga in före du kommenterar